●  Markets closed

Latest News & Earnings

New ETF launches1 new ETF hit the market · Oct 13
  • PEPTREX Peptide ETFequity0.65%

Just one new fund cleared EDGAR today: the REX Peptide ETF, an equity portfolio charging 0.65%, giving investors a single ticker on the GLP-1 era peptide drug boom instead of stock-picking it.

Biggest movers · At the close
  • NVTSNavitas Semiconductor$10.52+5.3%
  • VLOValero Energy$457.04+4.8%
  • ORCLOracle$143.28+4.3%
  • MPCMarathon Petroleum$476.94+4.0%
  • BPBP$48.57+3.9%
  • CIFRCipher Digital$11.29-13.1%
  • AMATApplied Materials$462.77-7.0%
  • SSentinelOne$24.05-6.3%
  • FNFabrinet$427.9-6.2%
  • GTLBGitLab$52.7-5.9%

Cipher Digital's 13.1% drop was the deepest cut in a 385-name priority list at the close. Refiners and Oracle took the other side.

CLOSING BELL
U.S. Markets
  • S&P 500-0.03%
  • Dow Jones Industrial Average-0.22%
  • Nasdaq Composite-0.16%

The S&P 500 finished within 2.6 points of where it started, holding the 7,800 line while the Dow gave up 114 points. Index-level calm is hiding a session where the selling was concentrated.

Reddit Pulser/povertyfinance
How is anyone surviving financially?

Two adults two incomes

A single $60,000 income supporting two adults no longer clears the bar, and 106 commenters mostly agreed the math only works with a second earner or a mortgage locked in years ago. The quiet lesson: one spouse's health problem is the fastest route from solvent to drained.

ABBVAbbVie
Regular session
$273.85
-3.06%open $282.50

A 3.1% slide to $273.85 lands minutes after new Phase 3 AFFIRM data for subcutaneous Skyrizi in Crohn's disease hit the wire. Skyrizi is the growth engine meant to carry the post-Humira era, so the market's read on this data matters.